
北美荧光免疫分析市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品类型(ELISA、快速侧流免疫分析等)、应用(传染病、肿瘤学、心血管疾病等)、和最终用户(医院和诊所、诊断中心、制药和生物技术公司、学术和研究机构等)
No. of Pages: 153 | Report Code: BMIRE00025665 | Category: Life Sciences
No. of Pages: 153 | Report Code: BMIRE00025665 | Category: Life Sciences
北美荧光免疫分析市场预计将从2021年的10.7241亿美元增长到2028年的15.9858亿美元;预计 2021 年至 2028 年复合年增长率为 5.9%。
荧光免疫分析是用于质量控制和抗原和抗原的定量特异性检测的诊断工具。抗体。该技术源自抗原抗体结合的基本免疫学概念。这些用于筛选以量化与疾病靶标相关的抗原/半抗原的产生或抑制。这些抗原或半抗原是疾病过程的特征,并且由靶标介导,例如细胞因子或生长因子。细胞疗法是利用细胞材料通过其生物活性和特性在体外或体内产生所需效果的实践。用于治疗的细胞可分为同种异体细胞或自体细胞。现代细胞疗法还包括再生人体细胞、组织或器官。所用细胞的基础来自干细胞和祖细胞、成熟且功能分化的细胞或人工产生的组织。荧光激活细胞分选 (FACS) 是一种高度灵活的技术,具有多种干细胞分选选项。这也是使用多个内部和外部标记分离特定干细胞群的唯一方法。 FACS 是一种特殊类型的流式细胞术,可根据每个细胞的特定光散射和荧光特性对异质细胞混合物进行分类。首先用荧光抗体标记细胞,该抗体与靶细胞上的相关蛋白质结合。单细胞通过激光束,检测器测量荧光、前向散射光 (FSC) 和侧向扩散光 (SSC)。 FSC 和 SSC 用于确定细胞的大小。可以同时检测多个波长的荧光,但这取决于仪器的特定激光器、滤光片和检测器。然后,根据捕获的测量结果和用户输入的参数,将电池物理分类到不同的容器中。荧光激活细胞分选可满足当前和未来细胞分离的需要,以进行有效的干细胞研究。因此,对荧光免疫分析的需求不断增长,以提供抗原和抗体的质量和数量特异性检测。
借助新功能和技术,供应商可以吸引新客户并扩大业务范围他们的足迹遍布新兴市场。这一因素可能会在预测期内推动北美荧光免疫分析市场实现显着的复合年增长率。
2028 年北美荧光免疫分析市场收入及预测(百万美元)
北美荧光免疫分析市场细分
北美荧光免疫分析市场按产品类型、应用、最终用户和国家/地区进行细分。根据产品类型,市场分为 ELISA、快速侧流免疫分析等。 ELISA 领域在 2021 年占据市场主导地位,预计在预测期内复合年增长率最高。根据应用,市场分为传染病、肿瘤、心血管疾病等。传染病细分市场在 2021 年占据主导地位,预计在预测期内复合年增长率最高。根据最终用户,市场分为医院和医疗机构。诊所、诊断中心、制药和医疗中心生物技术公司、学术界和研究机构等。医院和诊所领域在 2021 年占据市场主导地位,预计在预测期内复合年增长率最高。根据国家/地区,北美荧光免疫分析市场分为美国、加拿大和墨西哥。
雅培、BD、bioMerieux SA、丹纳赫、F. Hoffmann-La Roche Ltd.、Ortho Clinical Diagnostics Holdings plc、Quidel Corporation、西门子AG、Sysmex Corporation 和 Thermo Fisher Scientific Inc. 是北美荧光免疫分析市场的领先公司之一。
Strategic insights for North America Fluorescent Immunoassay involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1,072.41 Million |
Market Size by 2028 | US$ 1,598.58 Million |
Global CAGR (2021 - 2028) | 5.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Fluorescent Immunoassay refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Fluorescent Immunoassay Market is valued at US$ 1,072.41 Million in 2021, it is projected to reach US$ 1,598.58 Million by 2028.
As per our report North America Fluorescent Immunoassay Market, the market size is valued at US$ 1,072.41 Million in 2021, projecting it to reach US$ 1,598.58 Million by 2028. This translates to a CAGR of approximately 5.9% during the forecast period.
The North America Fluorescent Immunoassay Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Fluorescent Immunoassay Market report:
The North America Fluorescent Immunoassay Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Fluorescent Immunoassay Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Fluorescent Immunoassay Market value chain can benefit from the information contained in a comprehensive market report.